Atherosclerotic plaque rupture with thrombosis is the pathologic mechanism responsible for the majority of acute myocardial infarctions (AMI) and sudden coronary death (SCD). The hypothesized precursor lesion associated with plaque rupture has been termed "thin cap fibroatheroma" (TCFA), also known as "vulnerable plaque." In this brief article, we will discuss the pathology of coronary thrombosis, with emphasis on plaque rupture and its hypothesized precursor lesion, the thin cap fibroatheroma (TCFA). 
Luminal Thrombosis and ACSs
Patients with acute coronary syndromes (ACSs) classically present with unstable angina, acute myocardial infarction, or sudden coronary death. In approximately 50-60% of sudden coronary death cases, the culprit lesion exhibits an acute coronary thrombus, whereas the remainder of these cases include stable coronary plaques with greater than 75% cross-sectional area luminal narrowing. It is now recognized that the preexisting thin cap fibroatheroma (TCFA) (vulnerable plaque) in approximately 50% of patients dying from sudden thrombotic occlusion occurs as a hemodynamically insignificant lesion. The onset of symptoms and life-threatening complications therefore depend not only on the severity of narrowing in stable chronic anatomic disease but also on critical dynamic morphologicchanges in coronary plaque in the arterial wall.
Sudden luminal thrombosis may arise from 3 different plaque morphologies: plaque rupture, erosion, and calcified nodule. Of these 3, plaque rupture is the most frequent, accounting for 60-75% of cases.
Plaque rupture is defined as a lesion consisting of a lipid-rich necrotic core with an overlying thin, ruptured, fibrous cap heavily infiltrated by macrophages and T lymphocytes (see the image below). Although the precise mechanisms of plaque rupture are poorly understood, most researchers agree that disruption of a fibrous cap rich in macrophages and T lymphocytes in addition to the necrotic core coming in contact with circulating blood are events that lead to the development of thrombi in fatal plaques. [2, 3]
Thrombosis occurs when platelets and inflammatory cells in the circulating blood come into contact with the thrombogenic necrotic core. Previously, the necrotic core was thought to be the major source of tissue factor. It is now believed that circulating monocytes as well as plaque macrophages support the development of acute thrombi in unstable coronary plaques. 
The incidence of plaque rupture varies with each decade of life, and the highest incidence of rupture is seen in the 40s in men, whereas in women the incidence increases beyond age 50 years. Plaque rupture is a more frequent cause of coronary thrombosis in men than in women, and there is a strong association with circulating total cholesterol. The incidence of rupture beyond 50 years is similar for both sexes.
Plaque erosion is defined as an acute thrombus in direct contact with the intima in an area of denuded endothelium.  Histologically, luminal thrombus is present with an underlying base rich in proteoglycans and smooth muscle cells with minimal inflammation. Most erosions lack a necrotic core but when present, a thick fibrous cap sequesters the necrotic core, preventing communication with the lumen. In addition, eroded lesions tend to be eccentric and are rarely calcified. These plaques account for 25-40% of all coronary thrombi in sudden coronary death (see the following image).
Plaque erosion occurs primarily in patients younger than age 50 years and represents the majority of acute coronary thrombi in premenopausal women, especially women with a history of tobacco use. Approximately, 20-25% of acute myocardial infarctions occurring in hospitalized patients are due to plaque erosion, and the relative proportion of erosions (compared with plaque rupture) is higher in women than men.
Autopsy studies in sudden coronary death victims have shown that greater than 85% of thrombi in erosions exhibit late stages of healing characterized by acute inflammatory cell lysis, invasion by smooth muscle cells and/or endothelial cells, or organized layers of smooth muscle cells and proteoglycans with varying degrees of platelet/fibrin layering, whereas in ruptures only half of thrombi show healing.  Postmortem coronary thrombi superimposed on eroded plaques have been shown to contain a higher density of myeloperoxidase-positive cells than those superimposed on ruptured plaques.  In addition, circulation blood myeloperoxidase levels are elevated in patients with ACS with erosion as compared with those with rupture, suggesting that elevations in selective inflammatory biomarkers may reflect specific acute coronary events. 
The calcified nodule is the least common cause of coronary thrombosis (2-7%). These lesions typically contain a calcified plate with superimposed calcified nodules that result in discontinuity of the fibrous cap. The luminal thrombus is in direct contact with calcium nodules in areas devoid of endothelial cells (see the image below).
Plaque Rupture and the TCFA
Morphologic studies have identified coronary lesions that share many histologic similarities with plaque rupture and are therefore hypothesized to be the precursor lesion of plaque rupture. Those precursor plaques that closely resemble ruptures but lack a luminal thrombus have been characterized as thin-cap fibroatheromas (TCFAs), or vulnerable plaques.
As previously described, plaque ruptures are characterized by a necrotic core with an overlying thin-ruptured fibrous cap infiltrated by macrophages and lymphocytes. The thickness of the cap near the rupture site measures 23 ± 19 µm, with 95% of the caps measuring < 65 µm. The TCFA, like the rupture, demonstrates a necrotic core with an overlying fibrous cap (measuring less than 65 µm in thickness) but lacks a thrombus (see the following image).
Despite many similarities, several morphologic features distinguish the TCFA from the ruptured plaque. For example, TCFAs demonstrate a smaller necrotic core, fewer macrophages infiltrating the fibrous cap, and significantly less calcification. Other plaque features have been analyzed and compared for these 2 lesions as well as erosions and stable plaques. Overall, cross-sectional luminal narrowing is greater in ruptures than TCFAs, with occlusive thrombi having greater underlying stenosis than nonocclusive thrombi. The number of cholesterol clefts in the necrotic core, vasa vasorum, and macrophages are significantly greater in ruptures than erosions or stenotic stable lesions.
The necrotic core and its enlargement are critical for plaque rupture. It has been shown that macrophage infiltration is the first step toward the eventual formation of an atherosclerotic plaque. In vitro studies have shown that low-density lipoprotein (LDL) oxidation facilitates its uptake by macrophages. This 2-step process begins with oxidation of lipid, followed by apolipoprotein B oxidation. Foamy macrophages contain cholesterol esters and free cholesterol. However, as the plaque progresses, the free cholesterol content of the lesion increases, whereas the cholesterol esters decrease.
A study by Niccoli et al found that among patients with acute coronary syndrome, raised lipoprotein levels are associated with an increased atherosclerotic burden and it identifies a subset of patients with features of high risk coronary atherosclerosis. 
Intraplaque hemorrhage may also be an important contributor to expansion of the necrotic core. [9, 10] Hemorrhage into the atheroma may occur through leaky vasa vasorum and the subsequent accumulation of free cholesterol derived from erythrocyte membranes. Interestingly, the cholesterol content of erythrocyte membranes exceeds that of all other cells in the body, with lipid constituting 40% of the weight.
Location and Extent of Luminal Narrowing
The majority of thin-cap fibroatheromas (TCFAs) (vulnerable plaques), acute ruptures, and healed ruptures are concentrated in the proximal portion of the 3 major coronary arteries and another 50% arise in the mid-portion of these arteries (see the image below). These lesions are few in the distal coronary circulation. By far, the most frequent location is the proximal portion of the left anterior descending coronary artery; sites in the proximal left circumflex and mid to proximal right coronary arteries are about one half as common.
The extent of luminal narrowing varies with lesion morphology. Fibroatheromas have the least luminal narrowing, whereas lesions with acute plaque rupture, hemorrhage, or healed repair sites show the most stenosis. The vast majority of TCFAs (>80%) have less than 75% cross-sectional area luminal narrowing (equivalent to < 50% diameter stenosis).
During plaque development, outward remodeling of the artery occurs, essentially negating the flow-limiting potential when plaques occupy < 40% cross-sectional area luminal narrowing. TCFAs are associated with positive remodeling and therefore may show minimal luminal narrowing by angiography.
Role of Inflammation
Pathologic studies have demonstrated that inflammation contributes to the acute thrombotic complications of atherosclerosis. For example, it has been shown that fibrous cap thickness is related to the extent of macrophage infiltrate. Thin fibrous caps tend to demonstrate a greater number of macrophages compared with thick fibrous caps. Macrophages produce matrix metalloproteinases (MMPs), zinc-dependent endopeptidases, that possess catalytic activity.
Much interest has been focused on the role of MMPs as the main cause of fibrous cap disruption in plaque rupture.  Fibrillar collagens, especially type I, provide most of the tensile strength to the fibrous cap. The initial proteolytic nick in the collagen chain is provided by MMPs-1, -8 and -13, whereas the gelatinases MMP-2 and MMP-9 support collagen breakdown. It has been shown that atheromatous rather than fibrous plaques preferentially exhibit type I collagen cleavage occurring at sites that are rich in macrophages expressing both MMP-1 and MMP-13.
Clinical studies of coronary artery disease have shown that increased circulating levels of C-reactive protein (CRP), a positive acute-phase reactant, are an independent risk factor for cardiovascular disease. Pathologic studies have shown that the median serum CRP is significantly higher in victims of sudden coronary death dying from plaque rupture, erosion, and stable plaque relative to control subjects dying of noncoronary conditions.
In addition, there has been considerable interest in the role of other inflammatory proteins such as pregnancy-associated plasma protein-A, interleukin (IL)-6, IL-12, and oxidative products that may reflect the presence of chronic inflammation in the arterial wall or elsewhere in the body and thus may increase the risk of atherosclerosis.
A study by van Dijk et al found that transient CXCL13 expression, restricted presence of B cells in human atherosclerosis, along with formation of nonfunctional extranodal lymphoid structures in the phase preceding plaque rupture. The authors hypothesize that this indicates a change in the “inflammatory footprint” before and during plaque destabilization.